Bibliography

Found 1029 results

2018

Chettimada S, Lorenz DR, Misra V, Dillon ST, R Reeves K, Manickam C, Morgello S, Kirk GD, Mehta SH, Gabuzda D. Exosome markers associated with immune activation and oxidative stress in HIV patients on antiretroviral therapy. Sci Rep. 2018 ;8(1):7227.

Ginsberg SD, Alldred MJ, Gunnam SM, Schiroli C, Lee SHan, Morgello S, Fischer T. Expression profiling suggests microglial impairment in human immunodeficiency virus neuropathogenesis. Ann Neurol. 2018 ;83(2):406-417.

Gill AJ, Garza R, Ambegaokar SS, Gelman BB, Kolson DL. Heme oxygenase-1 promoter region (GT)n polymorphism associates with increased neuroimmune activation and risk for encephalitis in HIV infection. J Neuroinflammation. 2018 ;15(1):70.

Letendre S, Bharti A, Perez-Valero I, Hanson B, Franklin D, Woods SPaul, Gianella S, de Oliveira MFaria, Heaton RK, Grant I, et al. Higher Anti-Cytomegalovirus Immunoglobulin G Concentrations Are Associated With Worse Neurocognitive Performance During Suppressive Antiretroviral Therapy. Clin Infect Dis. 2018 ;67(5):770-777.

Guha D, Wagner MCE, Ayyavoo V. Human immunodeficiency virus type 1 (HIV-1)-mediated neuroinflammation dysregulates neurogranin and induces synaptodendritic injury. J Neuroinflammation. 2018 ;15(1):126.

Mukerji SS, Misra V, Lorenz DR, Uno H, Morgello S, Franklin D, Ellis RJ, Letendre S, Gabuzda D. Impact of Antiretroviral Regimens on Cerebrospinal Fluid Viral Escape in a Prospective Multicohort Study of Antiretroviral Therapy-Experienced Human Immunodeficiency Virus-1-Infected Adults in the United States. Clin Infect Dis. 2018 ;67(8):1182-1190.

Mukerji S, Misra I, Lorenz D, Uno H, Morgello S, Franklin D, Ellis R, Letendre S, Gabuzda D. Impact of ART regimens on CSF viral escape in HIV-1 infected adults. 2018 .

Sundermann E, Levine AJ, Horvath S, Moore D. Inflammation-Related Genes are Associated with Accelerated Aging in HIV. 2018 .

Elicer IM, Byrd D, Clark US, Morgello S, Robinson-Papp J. Motor function declines over time in human immunodeficiency virus and is associated with cerebrovascular disease, while HIV-associated neurocognitive disorder remains stable. J Neurovirol. 2018 ;24(4):514-522.

Underwood J, Cole JH, Leech R, Sharp DJ, Winston A. Multivariate Pattern Analysis of Volumetric Neuroimaging Data and Its Relationship With Cognitive Function in Treated HIV Disease. J Acquir Immune Defic Syndr. 2018 ;78(4):429-436.

Oppenheim H, Paolillo EW, Moore RC, Ellis RJ, Letendre SL, Jeste DV, Grant I, Moore DJ. Neurocognitive functioning predicts frailty index in HIV. Neurology. 2018 ;91(2):e162-e170.

Hellmuth J, Milanini B, Masliah E, Tartaglia MCarmela, Dunlop MB, Moore DJ, Javandel S, DeVaughn S, Valcour V. A neuropathologic diagnosis of Alzheimer's disease in an older adult with HIV-associated neurocognitive disorder. Neurocase. 2018 ;24(4):213-219.

Quach A, Horvath S, Nemanim N, Vatakis D, Witt MD, Miller EN, Detels R, Langfelder P, Shapshak P, Singer EJ, et al. No reliable gene expression biomarkers of current or impending neurocognitive impairment in peripheral blood monocytes of persons living with HIV. J Neurovirol. 2018 ;24(3):350-361.

Valdebenito S, Lou E, Baldoni J, Okafo G, Eugenin EA. The Novel Roles of Connexin Channels and Tunneling Nanotubes in Cancer Pathogenesis. Int J Mol Sci. 2018 ;19(5).

Sanfilippo C, Pinzone MR, Cambria D, Longo A, Palumbo M, Di Marco R, Condorelli F, Nunnari G, Malaguarnera L, Di Rosa M. OAS Gene Family Expression Is Associated with HIV-Related Neurocognitive Disorders. Mol Neurobiol. 2018 ;55(3):1905-1914.

Campbell L, Sundermann E, Letendre S, Kallianpur A, Hulgan T, Montoya J, Ellis R, Grant I, Heaton R, Moore DJ, et al. The relationship between amnestic mild cognitive impairment and biomarkers of inflammation among adults living with HIV. 2018 .

Gutierrez J, Murray J, Chon C, Morgello S. Relationship between brain large artery characteristics and their downstream arterioles. J Neurovirol. 2018 ;24(1):106-112.

Valdebenito S, Barreto A, Eugenin EA. The role of connexin and pannexin containing channels in the innate and acquired immune response. Biochim Biophys Acta Biomembr. 2018 ;1860(1):154-165.

Chiou B, Lucassen E, Sather M, Kallianpur A, Connor J. Semaphorin4A and H-ferritin utilize Tim-1 on human oligodendrocytes: A novel neuro-immune axis. Glia. 2018 ;66(7):1317-1330.

Sundermann EE, Heaton RK, Pasipanodya E, Moore RC, Paolillo EW, Rubin LH, Ellis R, Moore DJ. Sex differences in HIV-associated cognitive impairment. AIDS. 2018 ;32(18):2719-2726.

Nolan DJ, Rose R, Rodriguez PH, Salemi M, Singer EJ, Lamers SL, McGrath MS. The Spleen Is an HIV-1 Sanctuary During Combined Antiretroviral Therapy. AIDS Res Hum Retroviruses. 2018 ;34(1):123-125.

Robinson-Papp J, Navis A, Dhamoon MS, Clark US, Gutierrez-Contreras J, Morgello S. The Use of Visual Rating Scales to Quantify Brain MRI Lesions in Patients with HIV Infection. J Neuroimaging. 2018 ;28(2):217-224.

Robinson-Papp J, Nmashie A, Pedowitz E, Benn EKT, George MCatherine, Sharma S, Murray J, Machac J, Heiba S, Mehandru S, et al. Vagal dysfunction and small intestinal bacterial overgrowth: novel pathways to chronic inflammation in HIV. AIDS. 2018 ;32(9):1147-1156.

Gelman BB, Endsley J, Kolson D. When do models of NeuroAIDS faithfully imitate "the real thing"?. J Neurovirol. 2018 ;24(2):146-155.

2017

Fields JA, Metcalf J, Overk C, Adame A, Spencer B, Wrasidlo W, Florio J, Rockenstein E, He JJ, Masliah E. The anticancer drug sunitinib promotes autophagyand protects from neurotoxicity in an HIV-1 Tat model of neurodegeneration. J Neurovirol. 2017 ;23(2):290-303.

Pages